UA93901C2 - Вакцина против микоплазмы и вируса prrs - Google Patents

Вакцина против микоплазмы и вируса prrs

Info

Publication number
UA93901C2
UA93901C2 UAA200812024A UAA200812024A UA93901C2 UA 93901 C2 UA93901 C2 UA 93901C2 UA A200812024 A UAA200812024 A UA A200812024A UA A200812024 A UAA200812024 A UA A200812024A UA 93901 C2 UA93901 C2 UA 93901C2
Authority
UA
Ukraine
Prior art keywords
prrs
vaccine against
vaccine
against mycoplasma
immunogenic
Prior art date
Application number
UAA200812024A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Христа Сибила Дрекслер
Мартен Витвлит
Original Assignee
Интервет Интернешонал Б.B.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Интервет Интернешонал Б.B. filed Critical Интервет Интернешонал Б.B.
Publication of UA93901C2 publication Critical patent/UA93901C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
UAA200812024A 2006-04-10 2007-04-06 Вакцина против микоплазмы и вируса prrs UA93901C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112444 2006-04-10

Publications (1)

Publication Number Publication Date
UA93901C2 true UA93901C2 (ru) 2011-03-25

Family

ID=37114256

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200812024A UA93901C2 (ru) 2006-04-10 2007-04-06 Вакцина против микоплазмы и вируса prrs

Country Status (7)

Country Link
CN (1) CN101420975B (pt)
AT (1) ATE535253T1 (pt)
BR (1) BRPI0710550A2 (pt)
DK (1) DK2007419T3 (pt)
ES (1) ES2377576T3 (pt)
RU (1) RU2408386C2 (pt)
UA (1) UA93901C2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2571980A4 (en) 2010-05-19 2014-02-26 Bioproperties Pty Ltd METHOD RELATED TO A WEAKEN MYCOPLASMA
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
CN104248759B (zh) * 2013-11-19 2017-05-10 普莱柯生物工程股份有限公司 一种疫苗组合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine
WO2005112995A1 (en) * 2004-04-26 2005-12-01 Choongang Vaccine Laboratory Co., Ltd. Inactivated mixed vaccine for porcine respiratory disease and the method of manufacturing thereof

Also Published As

Publication number Publication date
BRPI0710550A2 (pt) 2011-08-16
CN101420975A (zh) 2009-04-29
DK2007419T3 (da) 2012-03-19
RU2408386C2 (ru) 2011-01-10
ES2377576T3 (es) 2012-03-29
CN101420975B (zh) 2012-06-27
ATE535253T1 (de) 2011-12-15
RU2008144180A (ru) 2010-05-20

Similar Documents

Publication Publication Date Title
CY1120347T1 (el) Εμβολιο ιου ερπητα ζωστηρα
MX2009008577A (es) Prevencion y tratamiento contra la enfermedad asociada a arcovirus porcion sub-clinica.
EA201100268A1 (ru) Вакцина
CL2013002379A1 (es) Virus del sindrome reproductor y respiratorio porcino (prrsv); procedimiento para la preparacion del prrsv atenuado vivo; vacuna que lo comprende y su procedimiento de preparacion; y procedimiento para inmunizar cerdos contra el sindrome reproductor y respiratorio porcino.
MX355683B (es) Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel, y métodos relacionados de preparación y uso.
BRPI0606539A2 (pt) vacinas aperfeiçoadas contra a prrs
MX2009006541A (es) Tratamiento de prdc en cerdos.
MX338898B (es) Vacuna contra el virus del dengue inactivado con un adyuvante libre de aluminio.
IN2012DN02736A (pt)
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
MX2009004862A (es) Estabilizacion de vacunas por liofilizacion.
MX2013000642A (es) Composiciones farmaceuticas.
EP2328612A4 (en) VACCINE AGAINST HIGH PATHOGENIC DISEASED LATE LIVESTOCK (PRRS)
WO2012027365A3 (en) Targeted multi-epitope dosage forms for induction of an immune response to antigens
WO2007120673A3 (en) Immunogenic wt-1 peptides and methods of use thereof
MX349119B (es) Vacuna de virus de dengue inactivado.
TN2011000182A1 (en) Live, attentuated respiratory syncytial virus
MX2010003719A (es) Vacuna de mycoplasma bovis y metodos de uso de la misma.
BR112015021523A2 (pt) composição de uma vacina contra a tosse convulsa acelular, e, métodos para vacinar um sujeito contra a bordetella pertussis e para proteger um sujeito da tosse convulsa
MX349990B (es) Composiciones de cuidado oral.
CA2646574A1 (en) Vaccine against mycoplasma and prrsv
UA93901C2 (ru) Вакцина против микоплазмы и вируса prrs
MY172788A (en) Influenza vaccines
GB2444676A (en) Adjuvanted vaccine
WO2011074006A3 (en) Vaccine composition